LEADER 01133nam--2200373---450-
001 990002731540203316
005 20070115162148.0
010   $a88-420-4781-3
035   $a000273154
035   $aUSA01000273154
035   $a(ALEPH)000273154USA01
035   $a000273154
100   $a20060407d1995----km-y0itay50------ba
101 0 $aita
102   $aIT
105   $a||||||||001yy
200 1 $aStoria della medicina e della sanita in Italia$edalla peste europea alla guerra mondiale, 1348-1918$fGiorgio Cosmacini
210   $aRoma [etc.]$cLaterza$d1995
215   $aXIV, 448 p.$d21 cm
225 2 $aEL$v67
410  0$12001$aEL$v67
606 0 $aMedicina$yItalia$zSec. 14.-19.
606 0 $aSanita pubblica$yItalia$zSec. 14.-19.
676   $a610.945
700  1$aCOSMACINI,$bGiorgio$0140184
801  0$aIT$bsalbc$gISBD
912   $a990002731540203316
951   $aSANT.9$b1312 DDPG$cSANT.
959   $aBK
969   $aDDPG
979   $aDDPG1$b90$c20060407$lUSA01$h1034
979   $aDDPG1$b90$c20070115$lUSA01$h1621
996   $aStoria della medicina e della sanità in Italia$9105322
997   $aUNISA

LEADER 01537nam  2200397Ia 450 
001 9910698867703321
005 20090512123704.0
035   $a(CKB)5470000002397187
035   $a(OCoLC)320838766
035   $a(EXLCZ)995470000002397187
100   $a20090512d2006      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $esupplemental guidance on testing for replication competent retrovirus in reroviral vector based gene therapy products and during follow-up of patients in clinical trials using retroviral vectors
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[2006]
215   $ai, 13 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May, 12, 2009).
300   $a"November 2006."
320   $aIncludes bibliographical references (pages 10-11).
517   $aGuidance for industry 
606   $aGene therapy$zUnited States$xTesting
606   $aRetroviruses$zUnited States
606   $aClinical trials$zUnited States
615  0$aGene therapy$xTesting.
615  0$aRetroviruses
615  0$aClinical trials
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698867703321
996   $aGuidance for industry$93434577
997   $aUNINA